Stocks › GDRX
GoodRx GDRX
US equityMarket cap rank #3098
$3.51 +$0.02 (+0.57%)
Market closed · Nov 7, 5:10 am ET · Last extended-hours $3.54 +0.85%
Open$3.43
Prev close$3.49
Day range$3.33 – $3.55
Volume1.17M
Market cap$1.20B
P/E (TTM)58.5
Dividend yield–
GDRX Stock News
Headlines matching GoodRx or the GDRX ticker, most recent first.
- BofA Securities Maintains GoodRx(GDRX.US) With Sell Rating, Maintains Target Price $2.65
- Goldman Sachs Maintains GoodRx(GDRX.US) With Hold Rating, Raises Target Price to $4 Positive
- Morgan Stanley Maintains GoodRx(GDRX.US) With Hold Rating, Raises Target Price to $4 Positive
- Raymond James Maintains GoodRx(GDRX.US) With Buy Rating, Announces Target Price $4.5
- A Quick Look at Today's Ratings for GoodRx(GDRX.US), With a Forecast Between $4 to $5
- Analysts' Opinions Are Mixed on These Healthcare Stocks: GoodRx Holdings (GDRX), Xencor (XNCR) and PepGen Inc. (PEPG)
- GoodRx(GDRX.US) 10% Shareholder Sells US$5.48 Million in Common Stock
- BofA Securities Maintains GoodRx(GDRX.US) With Sell Rating, Raises Target Price to $2.65 Positive
- GoodRx(GDRX.US) 10% Shareholder Sells US$4.2 Million in Common Stock
- Truist Financial Maintains GoodRx(GDRX.US) With Hold Rating
- TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $5
- UBS Maintains GoodRx(GDRX.US) With Hold Rating, Raises Target Price to $3.75 Positive
- TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Raises Target Price to $5 Positive
- Citi Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $5
- Citi Maintains GoodRx(GDRX.US) With Buy Rating, Raises Target Price to $5 Positive
No comments yet — be the first to weigh in on GDRX.
Sign in to join the discussion.